Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?

Liyuan Xiang; Xiao Ding; Qianqian Li; Xia Wu; Min Dai; Chuyan Long; Zhi He; Bota Cui; Faming Zhang

doi:https://doi.org/10.1111/1751-7915.13536

doi.org/10.1111/1751-7915.13536

Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?

,

,

..., Faming Zhang

32

Microbial biotechnology5.70

Volume: 13, Issue: 3, Pages: 760 - 769

Published: Jan 20, 2020

Abstract

Summary The efficacy of faecal microbiota transplantation (FMT) in Crohn’s disease (CD) remains unclear due to lack of data. This study aimed to assess the value of FMT in treating CD‐related clinical targets. The use of FMT for CD as a registered trial (NCT01793831) was performed between October 2012 and December 2017. Seven therapeutic targets included abdominal pain, diarrhoea, hematochezia, fever, steroid‐dependence, enterocutaneous fistula...